Clinical Trials at University of California, San Diego
As of September 2026, 40 paid clinical trials are recruiting at University of California, San Diego, located at 9500 GILMAN DRIVE #0039, LA JOLLA, CA 92093-0039, phone (858) 534-2588 in La Jolla, California. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in La Jolla
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery
42 clinical trials at University of California, San Diego
·Clear filters·Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Study of GS-0151 in Participants With Rheumatoid Arthritis
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Danon Disease Natural History Study
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury
ViewFlex X ICE First-in-Human Study
Precision Pain Management - A Randomized Clinical Trial Assessing the Efficacy of Suzetrigine on Postoperative Analgesia Among Surgical Patients at Higher Risk for Persistent Postoperative Opioid Use (POU)
Multivitamin and Mineral Supplementation and Healthy Aging
Interpersonal Brain Function in Opioid Use
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Clinical and Molecular Studies in Families With Inherited Eye Disease
Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas
Closed Loop and Education for Hypoglycemia Awareness Restoration
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer
Total RadIoTherapy of Oligometastatic caNcerS
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Focal Therapy for Localized Prostate Cancer
Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty
Pridopidine Phase 3 Study in Huntington's Disease
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Common conditions studied in La Jolla
- Breast Cancer (14 active studies)
- Prostate Cancer (12 active studies)
- Colorectal Cancer (11 active studies)
- Ovarian Cancer (11 active studies)
- Advanced Solid Tumor (10 active studies)
- Heart Failure (10 active studies)
Leading research sponsors in La Jolla
- University of California, San Diego
- National Cancer Institute (NCI)
- AstraZeneca
- Eli Lilly and Company
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in La Jolla?
There are approximately 534 recruiting clinical trials in La Jolla, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in La Jolla pay participants?
Most recruiting trials in La Jolla compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in La Jolla?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in La Jolla?
The most common conditions under active study in La Jolla include Breast Cancer (14), Prostate Cancer (12), Colorectal Cancer (11), Ovarian Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in La Jolla?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in La Jolla on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in La Jolla?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in La Jolla?
Recruiting research sites in La Jolla include UC San Diego Moores Cancer Center, University of California San Diego, University of California, San Diego, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in La Jolla right now?
The largest active categories in La Jolla are Cancer & tumors (185), Neurology & pain (44), Cardiovascular (31). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of California, San Diego?
University of California, San Diego is located at 9500 GILMAN DRIVE #0039, LA JOLLA, CA 92093-0039. Use the Google Maps link in the intro above to get directions.
How do I contact University of California, San Diego?
You can reach University of California, San Diego by phone at (858) 534-2588. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.